Screening of blood donors for antibody to human immunodeficiency virus type 1.
Identifieur interne : 000946 ( PubMed/Checkpoint ); précédent : 000945; suivant : 000947Screening of blood donors for antibody to human immunodeficiency virus type 1.
Auteurs : J K AcquayeSource :
- West African journal of medicine [ 0189-160X ]
Descripteurs français
- KwdFr :
- Analyse coût-bénéfice, Biais (épidémiologie), Donneurs de sang, Dépistage systématique (), Dépistage systématique (économie), Ghana (épidémiologie), Humains, Saisons, Sensibilité et spécificité, Sérodiagnostic du SIDA (), Sérodiagnostic du SIDA (économie), Séropositivité VIH (sang), Séropositivité VIH (épidémiologie), Séroprévalence du VIH, Test ELISA, Tests d'agglutination, Trousses de réactifs pour diagnostic, VIH-1 (Virus de l'Immunodéficience Humaine de type 1).
- MESH :
- sang : Séropositivité VIH.
- économie : Dépistage systématique, Sérodiagnostic du SIDA.
- épidémiologie : Ghana, Séropositivité VIH.
- Analyse coût-bénéfice, Biais (épidémiologie), Donneurs de sang, Dépistage systématique, Humains, Saisons, Sensibilité et spécificité, Sérodiagnostic du SIDA, Séroprévalence du VIH, Test ELISA, Tests d'agglutination, Trousses de réactifs pour diagnostic, VIH-1 (Virus de l'Immunodéficience Humaine de type 1).
- Wicri :
- geographic : Ghana.
English descriptors
- KwdEn :
- AIDS Serodiagnosis (economics), AIDS Serodiagnosis (methods), Agglutination Tests, Bias (Epidemiology), Blood Donors, Cost-Benefit Analysis, Enzyme-Linked Immunosorbent Assay, Ghana (epidemiology), HIV Seropositivity (blood), HIV Seropositivity (epidemiology), HIV Seroprevalence, HIV-1, Humans, Mass Screening (economics), Mass Screening (methods), Reagent Kits, Diagnostic, Seasons, Sensitivity and Specificity.
- MESH :
- chemical : Reagent Kits, Diagnostic.
- geographic , epidemiology : Ghana.
- blood : HIV Seropositivity.
- economics : AIDS Serodiagnosis, Mass Screening.
- epidemiology : HIV Seropositivity.
- methods : AIDS Serodiagnosis, Mass Screening.
- Agglutination Tests, Bias (Epidemiology), Blood Donors, Cost-Benefit Analysis, Enzyme-Linked Immunosorbent Assay, HIV Seroprevalence, HIV-1, Humans, Seasons, Sensitivity and Specificity.
Abstract
29,575 blood donors of whom about 20% were voluntary were screened for HIV 1. During the three years period 1988 to 1990 four different tests kits were used. Three were ELISA methods and one an agglutination method. Comparison of the monthly seropositivity for each year showed variations of 0.9 to 4.4% for the first year, 1.4 to 10% for the second year and 0.2 to 6.9% for the third year. The differences in the standard errors were found to be significant. These wide differences are suggested to be due to many factors including the use of different screening kits, many first time donors and inability to perform repeat tests on positive samples.
PubMed: 8398939
Affiliations:
Links toward previous steps (curation, corpus...)
Links to Exploration step
pubmed:8398939Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Screening of blood donors for antibody to human immunodeficiency virus type 1.</title><author><name sortKey="Acquaye, J K" sort="Acquaye, J K" uniqKey="Acquaye J" first="J K" last="Acquaye">J K Acquaye</name><affiliation><nlm:affiliation>National Blood Transfusion Service, Korle Bu Ghana.</nlm:affiliation><wicri:noCountry code="subField">Korle Bu Ghana</wicri:noCountry></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="????"><PubDate><MedlineDate>1993 Apr-Jun</MedlineDate></PubDate></date><idno type="RBID">pubmed:8398939</idno><idno type="pmid">8398939</idno><idno type="wicri:Area/PubMed/Corpus">000743</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000743</idno><idno type="wicri:Area/PubMed/Curation">000743</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000743</idno><idno type="wicri:Area/PubMed/Checkpoint">000743</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000743</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Screening of blood donors for antibody to human immunodeficiency virus type 1.</title><author><name sortKey="Acquaye, J K" sort="Acquaye, J K" uniqKey="Acquaye J" first="J K" last="Acquaye">J K Acquaye</name><affiliation><nlm:affiliation>National Blood Transfusion Service, Korle Bu Ghana.</nlm:affiliation><wicri:noCountry code="subField">Korle Bu Ghana</wicri:noCountry></affiliation></author></analytic><series><title level="j">West African journal of medicine</title><idno type="ISSN">0189-160X</idno></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>AIDS Serodiagnosis (economics)</term><term>AIDS Serodiagnosis (methods)</term><term>Agglutination Tests</term><term>Bias (Epidemiology)</term><term>Blood Donors</term><term>Cost-Benefit Analysis</term><term>Enzyme-Linked Immunosorbent Assay</term><term>Ghana (epidemiology)</term><term>HIV Seropositivity (blood)</term><term>HIV Seropositivity (epidemiology)</term><term>HIV Seroprevalence</term><term>HIV-1</term><term>Humans</term><term>Mass Screening (economics)</term><term>Mass Screening (methods)</term><term>Reagent Kits, Diagnostic</term><term>Seasons</term><term>Sensitivity and Specificity</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Analyse coût-bénéfice</term><term>Biais (épidémiologie)</term><term>Donneurs de sang</term><term>Dépistage systématique ()</term><term>Dépistage systématique (économie)</term><term>Ghana (épidémiologie)</term><term>Humains</term><term>Saisons</term><term>Sensibilité et spécificité</term><term>Sérodiagnostic du SIDA ()</term><term>Sérodiagnostic du SIDA (économie)</term><term>Séropositivité VIH (sang)</term><term>Séropositivité VIH (épidémiologie)</term><term>Séroprévalence du VIH</term><term>Test ELISA</term><term>Tests d'agglutination</term><term>Trousses de réactifs pour diagnostic</term><term>VIH-1 (Virus de l'Immunodéficience Humaine de type 1)</term></keywords><keywords scheme="MESH" type="chemical" xml:lang="en"><term>Reagent Kits, Diagnostic</term></keywords><keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en"><term>Ghana</term></keywords><keywords scheme="MESH" qualifier="blood" xml:lang="en"><term>HIV Seropositivity</term></keywords><keywords scheme="MESH" qualifier="economics" xml:lang="en"><term>AIDS Serodiagnosis</term><term>Mass Screening</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>HIV Seropositivity</term></keywords><keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>AIDS Serodiagnosis</term><term>Mass Screening</term></keywords><keywords scheme="MESH" qualifier="sang" xml:lang="fr"><term>Séropositivité VIH</term></keywords><keywords scheme="MESH" qualifier="économie" xml:lang="fr"><term>Dépistage systématique</term><term>Sérodiagnostic du SIDA</term></keywords><keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Ghana</term><term>Séropositivité VIH</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Agglutination Tests</term><term>Bias (Epidemiology)</term><term>Blood Donors</term><term>Cost-Benefit Analysis</term><term>Enzyme-Linked Immunosorbent Assay</term><term>HIV Seroprevalence</term><term>HIV-1</term><term>Humans</term><term>Seasons</term><term>Sensitivity and Specificity</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Analyse coût-bénéfice</term><term>Biais (épidémiologie)</term><term>Donneurs de sang</term><term>Dépistage systématique</term><term>Humains</term><term>Saisons</term><term>Sensibilité et spécificité</term><term>Sérodiagnostic du SIDA</term><term>Séroprévalence du VIH</term><term>Test ELISA</term><term>Tests d'agglutination</term><term>Trousses de réactifs pour diagnostic</term><term>VIH-1 (Virus de l'Immunodéficience Humaine de type 1)</term></keywords><keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>Ghana</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">29,575 blood donors of whom about 20% were voluntary were screened for HIV 1. During the three years period 1988 to 1990 four different tests kits were used. Three were ELISA methods and one an agglutination method. Comparison of the monthly seropositivity for each year showed variations of 0.9 to 4.4% for the first year, 1.4 to 10% for the second year and 0.2 to 6.9% for the third year. The differences in the standard errors were found to be significant. These wide differences are suggested to be due to many factors including the use of different screening kits, many first time donors and inability to perform repeat tests on positive samples.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">8398939</PMID><DateCreated><Year>1993</Year><Month>10</Month><Day>28</Day></DateCreated><DateCompleted><Year>1993</Year><Month>10</Month><Day>28</Day></DateCompleted><DateRevised><Year>2004</Year><Month>11</Month><Day>17</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0189-160X</ISSN><JournalIssue CitedMedium="Print"><Volume>12</Volume><Issue>2</Issue><PubDate><MedlineDate>1993 Apr-Jun</MedlineDate></PubDate></JournalIssue><Title>West African journal of medicine</Title><ISOAbbreviation>West Afr J Med</ISOAbbreviation></Journal><ArticleTitle>Screening of blood donors for antibody to human immunodeficiency virus type 1.</ArticleTitle><Pagination><MedlinePgn>93-5</MedlinePgn></Pagination><Abstract><AbstractText>29,575 blood donors of whom about 20% were voluntary were screened for HIV 1. During the three years period 1988 to 1990 four different tests kits were used. Three were ELISA methods and one an agglutination method. Comparison of the monthly seropositivity for each year showed variations of 0.9 to 4.4% for the first year, 1.4 to 10% for the second year and 0.2 to 6.9% for the third year. The differences in the standard errors were found to be significant. These wide differences are suggested to be due to many factors including the use of different screening kits, many first time donors and inability to perform repeat tests on positive samples.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Acquaye</LastName><ForeName>J K</ForeName><Initials>JK</Initials><AffiliationInfo><Affiliation>National Blood Transfusion Service, Korle Bu Ghana.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Nigeria</Country><MedlineTA>West Afr J Med</MedlineTA><NlmUniqueID>8301891</NlmUniqueID><ISSNLinking>0189-160X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011933">Reagent Kits, Diagnostic</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CitationSubset>J</CitationSubset><CitationSubset>X</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>West Afr J Med. 1993 Apr-Jun;12(2):76</RefSource><PMID Version="1">8398934</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D015492" MajorTopicYN="N">AIDS Serodiagnosis</DescriptorName><QualifierName UI="Q000191" MajorTopicYN="N">economics</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000372" MajorTopicYN="N">Agglutination Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015982" MajorTopicYN="N">Bias (Epidemiology)</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001782" MajorTopicYN="Y">Blood Donors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003362" MajorTopicYN="N">Cost-Benefit Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004797" MajorTopicYN="N">Enzyme-Linked Immunosorbent Assay</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005869" MajorTopicYN="N" Type="Geographic">Ghana</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006679" MajorTopicYN="N">HIV Seropositivity</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015528" MajorTopicYN="Y">HIV Seroprevalence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015497" MajorTopicYN="Y">HIV-1</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008403" MajorTopicYN="Y">Mass Screening</DescriptorName><QualifierName UI="Q000191" MajorTopicYN="N">economics</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011933" MajorTopicYN="N">Reagent Kits, Diagnostic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012621" MajorTopicYN="N">Seasons</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012680" MajorTopicYN="N">Sensitivity and Specificity</DescriptorName></MeshHeading></MeshHeadingList><OtherID Source="PIP">094485</OtherID><OtherID Source="POP">00240485</OtherID><OtherAbstract Type="PIP" Language="eng"><AbstractText>Between January 1988 and December 1990, the National Blood Transfusion Service in Ghana tested the blood of 29,575 blood donors for HIV-1 antibodies to examine the significance in variations in monthly seropositivity. More than 90% of the blood donors were first-time donors. 20% were voluntary donors and the remaining donors were family donors. Over the study period, the Service used 4 different test kits: Wellcome ELISA (January 1988-November 1989), hemagglutination method ( December 1989-February 1990), Wellcome recombinant ELISA (February-October 1990), Elavia ELISA (November-December 1990). It screened 9739, 9279, and 10,557 blood donors in 1988, 1989, and 1990, respectively. The monthly HIV-1 seropositivity rates were 0.9-4.4%, 1.4-10.1%, and 0.2-6.9% in 1988, 1989, and 1990, respectively. When the Service used just Wellcome recombinant ELISA (April-October 1990), the range was only 0.2-2%. Differences in the standard errors between the HIV-1 seropositivity rate for that month and that of the rest of the year were significant, especially in the 7-month period in which the Service used just the recombinant ELISA method. Contributing factors to the wide deviations included changes in testing kits, inability to repeat tests on all positive samples, and many first-time donors.</AbstractText></OtherAbstract><KeywordList Owner="PIP"><Keyword MajorTopicYN="N">Africa</Keyword><Keyword MajorTopicYN="N">Africa South Of The Sahara</Keyword><Keyword MajorTopicYN="Y">Blood Donors</Keyword><Keyword MajorTopicYN="Y">Blood Supply</Keyword><Keyword MajorTopicYN="Y">Comparative Studies</Keyword><Keyword MajorTopicYN="N">Developing Countries</Keyword><Keyword MajorTopicYN="N">English Speaking Africa</Keyword><Keyword MajorTopicYN="N">Equipment And Supplies</Keyword><Keyword MajorTopicYN="N">Examinations And Diagnoses</Keyword><Keyword MajorTopicYN="N">Ghana</Keyword><Keyword MajorTopicYN="Y">Hiv Serodiagnosis</Keyword><Keyword MajorTopicYN="N">Laboratory Examinations And Diagnoses</Keyword><Keyword MajorTopicYN="N">Measurement</Keyword><Keyword MajorTopicYN="Y">Screening</Keyword><Keyword MajorTopicYN="N">Studies</Keyword><Keyword MajorTopicYN="Y">Validity</Keyword><Keyword MajorTopicYN="N">Western Africa</Keyword></KeywordList><GeneralNote Owner="PIP">TJ: WEST AFRICAN JOURNAL OF MEDICINE.</GeneralNote></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1993</Year><Month>4</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>1993</Year><Month>4</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>1993</Year><Month>4</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">8398939</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list></list><tree><noCountry><name sortKey="Acquaye, J K" sort="Acquaye, J K" uniqKey="Acquaye J" first="J K" last="Acquaye">J K Acquaye</name></noCountry></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/SidaGhanaV1/Data/PubMed/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000946 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 000946 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= SidaGhanaV1
|flux= PubMed
|étape= Checkpoint
|type= RBID
|clé= pubmed:8398939
|texte= Screening of blood donors for antibody to human immunodeficiency virus type 1.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i -Sk "pubmed:8398939" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd \
| NlmPubMed2Wicri -a SidaGhanaV1
| This area was generated with Dilib version V0.6.31. |  |